Capital One Financial Corporation Stock Price Targets

Comprehensive analysis of short, mid, and long-term price targets for Capital One Financial Corporation (COF).

Back to Analysis Hub

Give me a comprehensive price target analysis for Capital One Financial Corporation (COF).

Below is a comprehensive, investor-focused analysis for Capital One Financial Corporation (COF) as of 2025-10-10, with the requested price-target trendlines drawn and a structured price-target view.

Drawn Price-Target Trendlines (Horizontal)

  • Low Target: 210.00 (green)
    • Extends from 2025-10-10 to 2025-11-09
    • Color: #2E8B57
  • Median Target: 260.00 (blue)
    • Extends from 2025-10-10 to 2025-11-09
    • Color: #1E90FF
  • High Target: 290.00 (orange)
    • Extends from 2025-10-10 to 2025-11-09
    • Color: #FF8C00

Notes on the trendlines: The three levels were plotted to the right edge of the chart (roughly 30 days forward from today) to visualize how COF would traverse near-term if prices gravitate toward the analyst targets. The exact levels and colors are reflected in the live chart via the drawing tool.

Executive Summary

  • Investment thesis: COF faces a challenging near term due to a GAAP earnings dip in the most recent quarter, but the forward narrative is more favorable as forward earnings risk normalizes and multiple should re-rate on improving revisions and a stronger balance sheet. The stock sits in an oversold technical condition with a meaningful set of potential catalysts in the 12–24 month horizon.
  • Price outlook: A base-to-bullish path exists if normalization of earnings and better-than-feared credit metrics unfold. The market is currently pricing in a difficult quarter (GAAP negative) but shows upside potential if normalized earnings and ROE/credit metrics stabilize.

Fundamental Analysis Key Valuation Metrics (as-available)

MetricValueCommentary
Current Price210.74Benchmark for relative valuation vs targets.
Market Cap134.77BLarge-cap bank holding company exposure.
Enterprise Value135.79BIncludes debt and cash considerations.
Trailing P/E585.39Extremely high due to recent earnings distortions; not meaningful on GAAP basis.
Forward P/E13.46Normalized earnings basis; more representative for valuation.
PEG RatioN/ANot provided / not meaningful given distortions.
Price to Book (P/B)1.28Modest premium to book; aligns with diversified bank risk.
Return on Equity (ROE)0.013%Extremely muted; reflects earnings distortions and capital structure.
Return on Assets (ROA)0.002%Very small; typical for bank balance-sheet leverage, but impacted by items.
Profit Margin0.0%GAAP profitability is not supporting margins currently.
Gross Margin0.0%Not meaningful for banks in the conventional sense.
Operating Margin-5.33%Indicates current period operating stress.
Debt to EquityN/ANot provided.
Total Cash60.996BStrong liquidity cushion.
Total Debt55.852BLeverage exists but cash balance is sizable.
Dividend Yield1.13%Modest dividend; five-year avg ~1.6%.
Five-Year Avg Dividend Yield1.60%Historical dividend level context.
Beta1.182Moderately bullish/bearish relative to market; not a dramatic beta.

Earnings Analysis Recent Earnings Performance

  • GAAP results (as shown in the earnings summary):
    • 2025-06-30 (0q): Net Income From Continuing Operation Net Minority Interest = -$4.263B; Diluted EPS = -8.58
    • 2025-03-31 (1q prior): Net Income = +$1.404B; Diluted EPS = +3.45
    • 2024-12-31: Net Income = +$1.093B; Diluted EPS = +2.67
    • 2024-09-30: Net Income = +$1.778B; Diluted EPS = +4.41
    • 2024-06-30: Net Income = +$0.597B; Diluted EPS = +1.38
  • Normalized/Adjusted earnings (2025-06-30 shown as a normalization figure):
    • Normalized Income: -$3.96B (0q)
    • 2025-03-31: +$1.654B
    • 2024-12-31: +$1.093B
    • 2024-09-30: +$1.778B
    • 2024-06-30: +$0.658B
  • Takeaway: The latest quarter carried a substantial GAAP charge (negative EPS) that drove the trailing P/E skyward. However, normalized/adjusted earnings remained positive in several prior quarters, suggesting a normalization path if charges subside.

EPS Trend

  • Current 0q (trailing) EPS: 4.35871
  • 7 days ago: 4.29459
  • 30 days ago: 4.2202
  • 60 days ago: 4.24087
  • 90 days ago: 4.1768
  • +1q: 3.88704 (current), with a trend higher over recent frames (3.80636, 3.78567, 3.843, 3.58638)
  • 0y: 17.70541 (current trailing), 17.648, 17.58892, 17.67892, 15.28915
  • +1y: 19.75928, 19.8037, 19.72995, 19.83489, 19.28007
  • Interpretation: Short-term EPS momentum shows a notable improvement sequence (0q around 4.36; +1q around 3.89), while year-ago measures look materially higher due to distinct periods in play. The presence of both GAAP and non-GAAP/normalized measures should be weighed together.

EPS Revisions

  • 0q (most recent): Up Last 7 days = 2; Up Last 30 days = 4; Down Last 30 days = 0; Down Last 7 days = 1
  • +1q: Up Last 7 days = 2; Up Last 30 days = 3; Down Last 30 days = 1; Down Last 7 days = 0
  • 0y: Up Last 7 days = 1; Up Last 30 days = 3; Down Last 30 days = 2; Down Last 7 days = 0
  • +1y: Up Last 7 days = 3; Up Last 30 days = 3; Down Last 30 days = 1; Down Last 7 days = 0 Interpretation: Net upward revisions are more common than downward revisions across the cited windows, indicating improving sentiment around COF’s earnings trajectory despite near-term distortions.

Technical Analysis (Last 60 Days Snapshot)

  • Current price: 210.74
  • 50-Day Moving Average (latest MA around mid-to-late Sep/early Oct):
    • The 50-day MA has been in the 218–219 range in recent periods; the price is trading below the 50-day MA, implying near-term weakness relative to this longer-term short-term trend.
  • RSI (14): Recently in the 17–18 region (extremely oversold), suggesting potential downside exhaustion and a near-term bounce could occur if buyers step in.
  • MACD (12,26,9): The MACD is negative (around -2.5 to -1.1 near the latest data), with the MACD line below the signal line, indicating ongoing bearish momentum, but potential for a reversal if price action stabilizes.
  • Moving-average alignment and momentum:
    • Price below the 50-day MA suggests near-term weakness, but extreme oversold RSI opens the door to a technical rebound if fundamentals and sentiment stabilize.
  • Summary: Near-term technical setup is oversold with limited downside from current levels, aided by a robust balance-sheet and the potential for normalization in normalized earnings. The plotted trendlines (210/260/290) provide reference anchors for potential resistance and support interactions.

Analyst Consensus & Price Targets

  • Current price: 210.74
  • Number of analysts covering COF: 21
  • Target High / Low / Median / Mean:
    • Target High: 290.00
    • Target Low: 210.00
    • Target Median: 260.00
    • Target Mean: 254.43
  • Interpretation:
    • The median target of 260.00 implies about +23% upside from current levels (210.74). The mean target (~254.43) implies roughly +21% upside.
    • The low target of 210.00 suggests limited downside relative to current price, effectively around -0.2% to -0.7% from today’s level.
    • The distribution shows a wide range of views but overall aligns with a constructive medium-term view if normalized earnings lines up with expectations.

Price Target Analysis (Short, Mid, Long-Term)

  • Short-Term (3 months): Target: 210.00 (Low)

    • Justification: The stock is currently around the Low target, with near-term risk from the latest GAAP earnings miss. The oversold RSI supports a potential near-term bounce, but the fundamental read is still uncertain due to the unusual items and weak GAAP margin. The 210 target provides a price floor reference in a risk-off scenario.
    • Key Drivers: Near-term valuation floor, potential bounce on oversold conditions, any relief from nonrecurring charges or better-than-expected macro credit metrics.
    • Risks: Extended weakness from continued earnings volatility, macro headwinds, or worse-than-expected guidance.

  • Mid-Term (12 months): Target: 260.00 (Median)

    • Justification: The median target suggests a scenario where normalized earnings stabilize and COF re-rates on fundamentals and improving revisions. Forward P/E around 13.5 hints at a reasonable multiple given a normalization in earnings and cash generation.
    • Key Drivers: Positive EPS revisions momentum continuing, stabilization of net interest income and credit costs, improvement in ROE, and a resilient cash position supporting returns.
    • Risks: If normalized earnings fail to materialize or credit costs worsen, multiple expansion may be capped.

  • Long-Term (3+ years): Target: 290.00 (High)

    • Justification: The 3+ year view envisions sustained earnings normalization with multiple expansion as COF demonstrates durable profitability, enhanced efficiency, and balanced risk management in a steadier macro environment.
    • Key Drivers: Structural improvements in efficiency/margins (where feasible for a lender), loan growth in a favorable economy, continued strong liquidity position, and a stable or improving dividend policy.
    • Risks: Prolonged macro weakness, regulatory or regulatory-capital constraints, competitive pressures, or structural headwinds in the consumer finance space.

Key Risks & Opportunities

  • Major Risks

    • GAAP earnings volatility driven by unusual items and large one-off charges that distort trailing valuations (very high trailing P/E is not informative in the current quarter).
    • Operational margins are negative on a GAAP basis; earnings quality hinges on normalization of normalized/intrinsic earnings.
    • Potential macroeconomic headwinds affecting consumer spending, card spending, and credit quality could pressure profitability.
    • Price remains below the 50-day MA, suggesting short-term downside pressure if buyers don’t step in quickly.

  • Key Opportunities

    • The forward P/E of ~13.5 points to a reasonable valuation given normalized profitability and a robust balance sheet.
    • The EPS revisions have shown net upward momentum across multiple windows, signaling improving sentiment and potential earnings trajectory.
    • The strong cash position offers balance-sheet strength and optionality for share buybacks or accretive growth investments.

Investment Recommendation

  • Recommendation: Hold with a constructive bias over a 12–24 month horizon.
  • Rationale: The stock appears oversold on a near-term basis (RSI around 17–18) with a price around the lower end of the analyst-driven targets. The forward multiple (13.5x) is reasonable given normalized earnings, and the company maintains a robust cash cushion ($61B) against ~$56B in debt, supporting optionality and financial resilience. Analyst targets imply meaningful upside to around the mid-to-high 250s or even 290+ on higher appreciation scenarios, though this hinges on earnings normalization and macro stability.
  • Expected return potential (12–24 months): Approximately 20–25% in a base-to-bullish scenario, with higher upside potential (to 290) if normalization continues and momentum in EPS revisions persists. A conservative base-case is in the mid-20% range.

Price Target Summary (Numerical References)

  • Current Price: 210.74
  • 3-Month Target Range: 210.00 (Low) to 260.00 (Median) to 290.00 (High)
  • 12-Month Target (Median): 260.00
  • 12–24 Month Potential Return (based on Median Target): ~23% upside versus current
  • 12–24 Month Potential Return (based on High Target): ~37% upside versus current

Tables: Key Data and Figures

  • Key Metrics (selected) | Metric | Value | Commentary | |---|---:|---| | Current Price | 210.74 | Referenced in targets; base for upside/downside calculations. | | Market Cap | 134.77B | Large-cap financials exposure. | | Enterprise Value | 135.79B | Consolidates cash/debt picture. | | Trailing P/E | 585.39 | Largely distorted by recent unusual items; not indicative of ongoing earnings power. | | Forward P/E | 13.46 | More representative given normalization. | | P/B | 1.28 | Reasonable for a diversified bank. | | ROE | 0.013% | Very low due to earnings distortions; normalization is key. | | ROA | 0.002% | Low, typical for banks with substantial leverage. | | Operating Margin | -5.33% | Indicates near-term earnings pressure. | | Total Cash | 60.996B | Solid liquidity cushion. | | Total Debt | 55.852B | Manageable with cash balance. | | Dividend Yield | 1.13% | Modest payout; five-year avg ~1.6%. | | Beta | 1.182 | Market-relative risk exposure. | | 50-day MA (latest) | ~218–219 | Price below MA, indicating near-term weakness. | | RSI (14) | ~17–18 | Extremely oversold; potential bounce zone. | | MACD (12,26,9) | Negative; bearish momentum | Potential reversal if price stabilizes. |

  • Analyst Targets | Item | Value | |---|---:| | Current Price | 210.74 | | Number of Analysts | 21 | | Target High | 290.00 | | Target Low | 210.00 | | Target Median | 260.00 | | Target Mean | 254.43 |

  • Earnings Summary (selected) | Quarter | Net Income (Continuing Ops) | Diluted EPS | Normalized Income | Notes | |---|---:|---:|---:|---| | 2025-06-30 (0q) | -4.263B | -8.58 | -3.96B | GAAP large charge; normalization shows mixed picture. | | 2025-03-31 (1q) | 1.404B | 3.45 | 1.654B | Positive earnings frame prior to latest quarter. | | 2024-12-31 | 1.093B | 2.67 | 1.093B | Stabilizing trend before the latest quarter. | | 2024-09-30 | 1.778B | 4.41 | 1.778B | Strong quarterly performance in prior period. | | 2024-06-30 | 0.597B | 1.38 | 0.658B | Earlier normalization stage. |

  • EPS Trend (selected) | Period | Current | 7 Days Ago | 30 Days Ago | 60 Days Ago | 90 Days Ago | |---|---:|---:|---:|---:|---:| | 0q | 4.35871 | 4.29459 | 4.2202 | 4.24087 | 4.1768 | | +1q | 3.88704 | 3.80636 | 3.78567 | 3.843 | 3.58638 | | 0y | 17.70541 | 17.648 | 17.58892 | 17.67892 | 15.28915 | | +1y | 19.75928 | 19.8037 | 19.72995 | 19.83489 | 19.28007 |

  • EPS Revisions (0q, +1q, 0y, +1y) | Period | Up Last 7d | Up Last 30d | Down Last 30d | Down Last 7d | |---|---:|---:|---:|---:| | 0q | 2 | 4 | 0 | 1 | | +1q | 2 | 3 | 1 | 0 | | 0y | 1 | 3 | 2 | 0 | | +1y | 3 | 3 | 1 | 0 |

  • Technical Snapshot (latest) | Indicator | Value / Note | |---|---| | 50-day MA | ~218–219 (late Sep/early Oct) | | RSI (14) | ~17–18 (extremely oversold) | | MACD | Negative; potential for reversal if price stabilizes |

Key Takeaways

  • The equity currently trades near a defined near-term support (210) with a very oversold RSI suggesting a potential bounce, but GAAP earnings distortions and negative margins are a concern.
  • The forward valuation (~13.5x) is reasonable if earnings normalize; analyst targets imply ~20–25% upside on a 12–24 month horizon, with higher upside to 290 if earnings and sentiment improve meaningfully.
  • The drawn trendlines (210, 260, 290) provide clear reference levels for risk management and upside potential.

Recommendation Rationale and Time Horizon

  • View: Hold with a constructive bias over the next 12–24 months.
  • Why: The stock has a credible upside path on normalized earnings and positive revisions momentum, supported by a solid cash cushion. The risk is the near-term earnings distortion and macro risk in consumer finance. If normalized earnings persist and revisions stay positive, COF could move toward the 260–290 zone.
  • Expected Return Potential: Base-case around mid-teens to low-20s percentage-wise over 12–24 months; upside could extend toward the high-20s to low-30s if the 12–24 month targets are realized and the earnings story stabilizes.

Would you like me to add a sensitivity table showing potential outcomes given different normalization assumptions (e.g., normalized earnings growth of +2%, +5%, +8% and corresponding impact on forward P/E and target paths)?

Chart is loading...